Premium
The Alzheimer disease‐related calcium‐binding protein Calmyrin is present in human forebrain with an altered distribution in Alzheimer's as compared to normal ageing brains
Author(s) -
Bernstein H.G.,
Blazejczyk M.,
Rudka T.,
Gundelfinger E. D.,
Dobrowolny H.,
Bogerts B.,
Kreutz M. R.,
Kuznicki J.,
Wojda U.
Publication year - 2005
Publication title -
neuropathology and applied neurobiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.538
H-Index - 95
eISSN - 1365-2990
pISSN - 0305-1846
DOI - 10.1111/j.1365-2990.2005.00646.x
Subject(s) - neocortex , hippocampal formation , dentate gyrus , biology , forebrain , neuroscience , human brain , alzheimer's disease , immunostaining , senile plaques , pathogenesis , pathology , central nervous system , medicine , immunohistochemistry , disease , immunology
The EF‐hand calcium binding protein Calmyrin (also called CIB‐1) was shown to interact with presenilin‐2 (PS‐2), suggesting that this interaction might play a role in the pathogenesis of Alzheimer's disease (AD). Here we have investigated the distribution of Calmyrin in normal human and AD brain. In normal brain Calmyrin immunoreactivity was unevenly distributed with immunostaining in pyramidal neurones and interneurones of the palaeo‐ and neocortex, cerebellar granule cells and hypothalamic neurones of the paraventricular, ventromedial and arcuate nuclei. Moderate immunoreactivity was present in hippocampal pyramidal cells and stronger in dentate gyrus neurones. Thalamic and septal neurones were devoid of immunoreactivity. No apparent differences were visible between stainings of brain sections from younger and older nondemented patients. In AD brain a substantial loss of Calmyrin‐immunopositive neurones was observed in all regions, especially in cortical areas. Still immunoreactive neurones, however, displayed stronger staining that was especially concentrated in perinuclear regions. Calmyrin immunosignals were in part associated with diffuse and senile plaques. Thus, although protein levels of Calmyrin are low in human forebrain, its cellular localization as well as its altered distribution in AD brain suggest that it may be involved in the pathogenesis of AD.